Jane Street Group, LLC Nu Cana PLC Transaction History

Jane Street Group, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.62 - $26.13 $13,999 - $590,015	22,580 New	22,580 $24,000
Q1 2022 May 17, 2022	SELL	$0.74 - $3.27 $9,178 - $40,561	-12,404 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$2.02 - $2.9 $25,056 - $35,971	12,404 New	12,404 $30,000

3.33M

Ticker NCNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,196,000
Market Cap $68.4M
Description
NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of products for the treatment of cancer. The company develops its products based on its proprietary ProTide technology. Its lead product candidate includes Acelarin, which is in Phase I clinical trial for patients with advanced solid tumors; Phase Ib for patients ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.